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Abstract: Microvascular abnormalities are one of the most important causes of persistent diabetic complications. The
aim of this study was to compare microvascular changes examined by nailfold capillaroscopy with serum concentra-
tions of soluble E-selectin (sE-selectin) and IL-18 in type 1 diabetic patients with and without microangiopathy.
Serum levels of sE-selectin and IL-18 were determined by an enzyme-linked immunosorbent assay in 106 patients
with type 1 diabetes and in 40 healthy controls. All diabetic patients were evaluated by extensive clinical, laboratory
and capillaroscopic studies. Morphological changes were observed by nailfold capillaroscopy in 86 out of 106 (81%)
diabetic patients. Severe capillaroscopic changes were seen in 32 out of 54 (59%) patients with microangiopathy, but
in only seven out of 52 (13%) patients without microangiopathy. Higher serum levels of sE-selectin (p < 0.001) and
IL-18 (p < 0.05) were demonstrated in diabetic patients compared to controls. Significant differences of sE-selectin
(p < 0.001) and IL-18 (p < 0.01) serum concentrations were observed between diabetic patients with microangio-
pathy and controls. Moreover, comparison between patients with and without microangiopathic complications showed
a significantly higher capillaroscopic score and sE-selectin serum concentration in the group with microangiopathy
(p < 0.001). Furthermore, diabetic patients with severe microvascular changes in capillaroscopy showed significantly
higher IL-18 (p < 0.001) and sE-selectin (p < 0.05) serum levels than subgroups without changes or with mild
abnormalities. Our findings suggest that abnormalities in nailfold capillaroscopy may reflect the extent of microvas-
cular involvement and are associated with higher sE-selectin and IL-18 serum levels, as well as with microangiopathic
complications in diabetic patients. (Folia Histochemica et Cytobiologica 2011; Vol. 49, No. 1, pp. 104–110)
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Introduction
Microvascular abnormalities are one of the most im-
portant causes of persistent diabetic complications.
Endothelial dysfunction plays a key role in the de-
velopment of vascular disease and represents an
early stage in the pathogenesis of diabetic microan-
giopathy [1].
Damaged or activated endothelial cells are a tar-
get and the source of various factors responsible for
the control of vascular tone, coagulation systems and
inflammatory processes, among which endothelial
selectin (E-selectin) has attracted attention as a speci-
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fic marker of endothelial activation and as an an-
giogenic mediator [2]. Stimulation of endothelial
cells leads to release of the soluble form of E-selec-
tin (sE-selectin), and its serum concentration might
be related to endothelial cell damage [3]. Increased
serum levels of sE-selectin have been reported in seve-
ral connective tissue diseases [4], coronary heart dise-
ase [5] and systemic inflammatory response syndrome
[6]. Moreover, it has been suggested that sE-selectin
plays an important role in the pathogenesis of mi-
crovasculature disorders in diabetes [7]. A previous
study demonstrated a relationship between sE-selectin
serum concentration and microvascular abnormali-
ties in nailfold capillaroscopy in patients with systemic
lupus erythematosus (SLE) [8].
Recently, it has been recognized that the inflam-
matory process accompanying  increased concentra-
tion of proinflammatory cytokines and plasma adhe-
sion molecules plays an important role in the patho-
genesis of diabetes [3].
Interleukin 18 is a proinflammatory cytokine
which exerts a number of biological activities [9]. In
pathological conditions, IL-18 is involved in angio-
genesis [10], arteriosclerosis [11], tissue destruction,
and seems to play a role in the autoimmune b-cell
destruction [12]. Recent studies have shown that cir-
culating IL-18 may be a predictor of progression of
diabetic nephropathy as well as cardiovascular dis-
eases [13].
Nailfold capillaroscopy (NC) has been used as
a non-invasive and sensitive technique for evaluating
microvascular involvement, mainly in connective tis-
sue diseases, including scleroderma-spectrum disor-
ders [14], systemic lupus erythematosus [8], juvenile
idiopathic arthritis [15] and other connective tissue
diseases [16].
Morphological and functional changes in capillary
microscopy have been reported in diabetic patients,
mainly in relation to vascular reactivity after induced
ischemia [17]. In our previous study, we evaluated the
relationship between microvascular abnormalities in
capillaroscopy and diabetic microangiopathy in pa-
tients with type 1 diabetes mellitus [18]. There has
also been found to be a relationship between the se-
verity of microvasculature changes and metabolic
control of diabetes [19].
Despite all these findings, little data exists on the
relationship between microvascular changes in capil-
laroscopy, disease feature, and endothelial cell acti-
vation markers. Therefore, the aim of this study was
to compare microvascular abnormalities examined by
nailfold capillaroscopy with serum concentrations of




The study included 106 patients with type 1 diabetes,
treated in the Clinical Department of Endocrinolo-
gy, Diabetology and Internal Diseases and Diabetic
Polyclinic of Clinical Hospital of Medical University
in Bialystok. The study was approved by the Ethics
Committee of the Medical University of Bialystok
(resolution No. R-I-002/96/2008), and informed con-
sent was obtained from each patient.
All patients were evaluated by clinical, laborato-
ry and capillaroscopic studies on the day of blood
sample collection. The weight and height of all pa-
tients was recorded, their BMI calculated and bio-
chemical parameters, such as HbA1c (HPLC Variant,
BIO-RAD Laboratories, Germany), total choles-
terol, HDL-cholesterol, triglycerides (TG) (enzyme
assay, ANALCO-GBG, Poland) and LDL-choles-
terol (calculated from Friedewald formula), were
measured.
Based on the medical records, the prevalence and
progress of chronic complications were determined.
According to clinical and laboratory examinations, the
whole group of diabetic patients was subdivided into
patients without (Group A, n = 52) and with microan-
giopathy (Group B, n = 54) i.e. retinopathy (45 pa-
tients), nephropathy (29 patients) and/or neuropathy
(41 patients). All diabetic patients were on insulin
therapy comprising at least three insulin doses per
day. Exclusion criteria from our study were: vascular
coexistent disorders, hypertension, hepatopathy,
smoking, active infection, vascular effective drug use
and hand lesions.
The control group consisted of 40 healthy volun-
teers comparable in terms of age, sex, and body mass
index. Table 1 shows the characteristics of the type 1
diabetic patient group and the control group.
Clinical and laboratory analysis
Ophtalmological and neurological examinations, re-
nal ultrasonography, renal function tests, peripheral
blood cell counts, hemoglobin concentration, serum
creatinine, creatinine clearance, urinalysis, albumi-
nuria, daily urinary protein excretion and erythrocyte
sedimentation rate (ESR) were performed for all
patients.
Serum specimen preparation
For the determination of serum analyses, venous
blood samples were collected, after overnight fasting,
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in tubes without additives. Serum was prepared from
blood samples by centrifugation at 3,000 g for 10 minu-
tes and then immediately transferred in aliquots into
plastic tubes and stored at –80°C.
Laboratory studies
The serum levels of sE-selectin and interleukin 18
concentrations were analyzed by ELISA kits (Parame-
ter Human sE-Selectin Immunoassay, R&D Systems
and Medical & Biological Laboratories, Freiburg,
Germany). The experimental procedures were per-
formed adhering strictly to the manufacturer’s in-
structions.
Nailfold capillaroscopy
All patients underwent a nailfold capillaroscopy exa-
mination using a stereomicroscope SZ 4045 with
a final magnification of × 200 (Olympus, Germany).
A fiber-optic light source and filter provided cold il-
lumination. The optical microscope was connected
to a color digital camera and a personal computer.
The images taken at the time of examination were
analyzed by the same experienced investigator
(AKM). Each patient was allowed to acclimatize for
20 minutes at a room temperature of 20–24°C before
the examination.
The nailfold of all fingers (not the thumbs) were
examined in 10–100 zoom after a drop of immer-
sion oil was placed on the nailfold bed. The mean
score for each patient was obtained from the ana-
lysis of all studied fingers. The loop density in 1 mm,
numbers and morphology of loops with architec-
tural derangement, and the presence of extravasa-
tions were evaluated. The intensity of morphologi-
cal changes was expressed according to the accep-
ted classification [8, 17] and ranged from 0 to 3:
a score of 0 indicated no changes (< 13 capillaries/
/mm, hairpin-shaped loops arranged in parallel
rows, absence of hemorrhages); a score of 1 = mild
(< 13 capillaries/mm, < 20% capillaries longer than
750 µm, < 50% morphologically changed capillar-
ies, arranged in parallel rows, absence of hemor-
rhages); a score of 2 = moderate (< 9 capillaries/
/mm, more than 20% capillaries longer than 750 mm,
50–75% changed loops with irregular distribution
of the capillary array, increased visibility of sub-
papillary venular plexus, without extravasations):
and a score of 3 = severe changes (< 9 capillaries/
/mm, capillary length variability, more than 75%
changed loops such as meandering, ramified and/
/or disarranged capillaries with the presence of he-
morrhages).
Statistical analysis
Statistical analysis of the results was carried out us-
ing Statistica 8.0 software from StatSoft. Data was
analyzed by the Mann–Whitney U-test. The proba-
bility of differences in frequency distributions was
determined by chi-square test or Fisher’s exact test.
In all calculations, p < 0.05 were considered statisti-
cally significant.
Results
There were no significant differences in age, gen-
der, body mass, growth or BMI between the group
of patients with type 1 diabetes and the healthy con-
trols. Biochemical parameters such as HbA1c con-
centration, total cholesterol, triglycerides, LDL-
-cholesterol and creatinine were significantly high-
er, and HDL-cholesterol level was significantly lo-
wer, in diabetic patients compared to the control
group (Table 1).
The NC patterns of 106 patients with type 1 dia-
betes and 40 healthy controls were examined in this
study. The capillaroscopic feature of the control
group showed hairpin capillaries in a parallel ar-
rangement. All healthy controls reached a capillaro-
scopic score = 0.
Patients with type 1 diabetes had spiral loops with
decreased density and dilatation of the apical part and
the venous limb. Normal capillaroscopic patterns
(score 0) were observed in 20 (19%), minor abnor-
malities (score 1) in 29 (27%), moderate in 18 (17%)
and severe in the remaining 39 of the 106 (37%) dia-
betic patients. The duration of disease was longer in
diabetic patients with severe capillaroscopic changes
(20.3 ± 10.2 years) than in patients with mild (12.63
± 10.9 years) or moderate (15.7 ± 10.8 years) mi-
crovascular abnormalities.
A comparison between the type 1 diabetic pa-
tients with (Group B) and those without microangi-
opathy (Group A), found there to be a significantly
higher capillaroscopic score in patients with (2.3 ±
± 1.0) than without microangiopathy (1.15 ± 1.0;
p<0.001). Severe morphological changes in nailfold
capillaroscopy were observed in 32 out of 54 (59%)
patients with microangiopathy but only in seven out
of 52 (13%) diabetic patients without microangiop-
athy. Moreover, normal capillaroscopic patterns or
minor abnormalities (score 0–1) were found in 15
(28%) patients from Group B compared to 34 (66%)
patients from Group A.
Serum levels of sE-selectin and IL-18 were deter-
mined in 106 type 1 diabetic patients, 52 of them with-
out microangiopathy and 54 with microangiopathic
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complications, and in 40 healthy subjects. Higher se-
rum concentrations of sE-selectin (p < 0.001) and
IL-18 (p < 0.05) were observed in diabetic patients
compared to the control group. Moreover, significant
differences of sE-selectin (p < 0.001) and IL-18 (p <
< 0.01) serum concentrations were observed between
diabetic patients with microangiopathy and controls.
Although patients with microangiopathy demonstra-
ted higher serum levels of IL-18 and sE-selectin than
patients without microangiopathy, significant diffe-
rences were only found in sE-selectin concentrations
(p < 0.05) (Table 2).
To demonstrate the relationships between capil-
laroscopic abnormalities, sE-selectin and IL-18 serum
levels, the four subgroups of diabetic patients were
distinguished according to the severity of capillaro-
scopic changes. Patients with severe capillaroscopic
abnormalities showed significantly higher sE-selec-
tin and IL-18 serum levels than patients with normal
capillaroscopic pattern or with mild changes (p < 0.05;
p < 0.001, respectively) (Tables 3, 4).
Discussion
Although progress in diagnostic and treatment pro-
cedures has dramatically improved the quality of life
for young diabetic patients, the mortality rate in this
group is still significantly higher than in the general
population, mostly due to the development of micro-
and macroangiopathic complications. It is claimed
that endothelial cell activation and damage play
a potentially crucial role in the pathogenesis of mi-
crovascular complications in diabetes [1, 10]. Hence,
the early diagnosis of vascular pathology is vital for
the therapy of diabetic patients. Therefore, growing
evidence points to the need for reliable methods of
visualizing the morphological changes in microcir-
culation.
Nailfold capillary microscopy has been used ex-
tensively as a non-invasive means of investigating
microvascular involvement. Our previous studies re-
ported the diagnostic value of nailfold capillary ab-
normalities and their correlation with organ systemic
Table 1. Clinical characteristic of diabetic patients and controls
Characteristics Patients p < Control group
(mean ± SD) (mean ± SD)
n = 106 n = 40
Age (years) 37.60 ± 12.83 NS 33.25 ± 10.06
Disease duration (years) 14.61±10.9 – –
BMI [kg/m2] 23.93 ± 4.05 NS 22.87 ± 3.5
HbA1c (%) 8.29 ± 2,27 0.001 4.53 ± 0.4
Total cholesterol [mg/dl] 191.19 ± 48.0 0.01 166.70 ± 22.6
Triglycerides [mg/dl] 117.66 ± 95.8 0.01 73.98 ± 33.4
HDL-cholesterol [mg/dl] 52.46 ± 14.8 0.01 60.35 ± 17.6
LDL-cholesterol [mg/dl] 115.19 ± 39.4 0.001 91.56 ± 25.5
Serum creatinine [mg/dl] 0.91 ± 0.30 0.001 0.73 ± 0.1
Retinopathy (no. of patients) 45 – –
Nephropathy (no. of patients) 29 – –
Neuropathy (no. of patients) 41 – –
NS — non significant
Table 2. Serum concentrations of soluble E-selectin (sE-selectin) [ng/ml] and IL-18 [pg/ml] in patients with type 1 diabetes
according to the presence of microangiopathy and in healthy controls. Data is shown as mean ± SD
Parameters                                                               Diabetic patients Together Controls
Without microangiopathy (n = 52) With microangiopathy (n = 54) (n = 106) (n = 40)
sE-selectin 56.86 ± 17.843 80.77 ± 51.991,4 69.04 ± 40.781 32.81 ± 10.14
IL-18 248.57 ± 84.40 267.99 ± 100.682 258.47 ± 93.123 217.41 ± 59.81
1Statistical significance: p < 0.001 compared to healthy controls; 2Statistical significance: p < 0.01 compared to healthy controls;
3Statistical significance: p < 0.05 compared to healthy controls; 4Statistical significance: p < 0.05 between both diabetic groups
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involvement and immunological parameters of dise-
ase activity in patients with connective tissue dise-
ases [8].
There is growing understanding of the microvas-
cular abnormalities in diabetes [17–19], but little is
known about the relationship between capillaroscopic
abnormalities, immunological parameters and the
clinical features of type 1 diabetes. Furthermore, ac-
cording to recent studies, chronic inflammation leads
to the impairment of endothelial function and mi-
crovascular complications in the course of diabetes
[3, 10]. Our previous report showed a relation between
the severity of capillaroscopic changes and metabolic
control and the presence of persistent complications
in patients with type 1 diabetes [18].
The present study evaluated the associations bet-
ween nailfold capillaroscopic abnormalities, sE-selec-
tin and IL-18 serum levels and the clinical features of
a cohort of 106 patients with type 1 diabetes. The in-
tensity of capillaroscopic changes, expressed accor-
ding to the established classification, ranged from 0
to 3 [8, 18].
The results of this study confirmed the findings of
other authors who have reported a pattern of capil-
lary changes expressed by decreased density, dilata-
tions of venous limb, increased tortuosity of vascular
loops and microaneurysms in the apical part of the
loop [17].
In the present study, severe capillaroscopic chang-
es were observed frequently in diabetic patients com-
plicated by microangiopathy. The mean capillarosco-
pic score in diabetic patients with microangiopathy
was significantly higher than in the group without
complications (p < 0.001).
Therefore, it may be suggested that microvas-
cular abnormalities in NC are an indicator to mi-
croangiopathy in diabetic patients, and useful in
monitoring the severity of vascular changes. It has
been suggested that increased pressure in the cap-
illary vascular bed [17], nonenzymatic glycation of
basal membrane proteins [20], endothelial dysfunc-
tion and angiogenic activity [1, 10] are implicated
in the pathogenesis of microcirculation disturbanc-
es in diabetes.
Our present study demonstrated the relationship
between the severity of capillaroscopic abnormali-
ties and disease duration. This may confirm our pre-
vious findings [18]. In addition, other authors have
reported the correlation between microvascular
changes in capillaroscopy and the occurrence of re-
tinopathy in 25 patients with type 1 diabetes [21].
Furthermore, in patients with type 2 diabetes, a re-
lationship has been shown between the occurrence
of hemostatic loops and disease duration, as well as
the presence of persistent complications [20]. How-
ever, other authors did not find differences between
Table 4. Serum concentrations of IL18 in patients with type 1 diabetes according to the severity of microvascular changes
in capillaroscopy and in healthy controls
Capillaroscopic abnormalities IL-18 mean ± SD [pg/ml] Together Controls
Score (n = 106) (n = 40)
0 218.67 ± 63.772
1 212.79 ± 74.563
258.47 ± 93.121 217.41 ± 59.81
2 259.12 ± 73.371
3 312.53 ± 99.99
1Statistical significance: p < 0.05 compared to healthy controls; 2Statistical significance: p < 0 001 between diabetic groups (0 and 3);
3Statistical significance: p < 0.001 between diabetic groups (1 and 3)
Table 3. Serum concentrations of soluble E-selectin (sE-selectin) in patients with type 1 diabetes according to the severity
of microvascular changes in capillaroscopy and in healthy controls
Capillaroscopic abnormalities sE-selectin (mean ± SD) [ng/ml] Together Controls
Score (n = 106) (n = 40)
0 55.40 ± 16.421, 3
1 55.05 ± 18.351, 4
69.04 ± 40.781 32.81 ± 10.14
2 65.65 ± 18.351
3 88.00 ± 58.522
1Statistical significance: p < 0.001 compared to healthy controls; 2Statistical significance: p < 0.05 compared to healthy controls;
3Statistical significance: p < 0.05 between diabetic groups (0 and 3); 4Statistical significance: p < 0.05 between diabetic groups (1 and 3)
109Capillaroscopy and microcirculation in type 1 diabetes
©Polish Society for Histochemistry and Cytochemistry
Folia Histochem Cytobiol. 2011
10.5603/FHC.2011.0015
www.fhc.viamedica.pl
the capillaroscopic features of type 1 diabetic pa-
tients and those of healthy volunteers [22].
The results of this study confirm that serum sE-
-selectin was significantly elevated in patients with
capillaroscopic abnormalities in diabetic microangi-
opathy such as retinopathy, nephropathy or neurop-
athy, compared to a subgroup without microvascular
changes. Moreover, we found significant differences
in sE-selectin serum concentrations between diabetes
patients with severe capillaroscopic changes and the
subgroup without or with mild capillaroscopic changes
(p < 0.05). Several studies have demonstrated ele-
vated levels of sE-selectin in patients with diabetes
[23]. Moreover, there was shown to be a positive cor-
relation between the serum sE-selectin levels and the
presence of retinopathy, albuminuria and cardiovas-
cular system diseases in 540 patients with type 1 dia-
betes in the EURODIAB Prospective Complication
Study [24]. By contrast, according to other studies,
serum levels of sE-selectin are not related to the pre-
sence of diabetic kidney disease in patients with type
1 diabetes [25].
In our study, we demonstrated significantly ele-
vated levels of IL-18 in serum of type 1 diabetes pa-
tients, and in all subgroups with capillaroscopic ab-
normalities, compared to healthy controls. More-
over, the serum concentration of IL-18 was signifi-
cantly higher in patients with severe microvascular
changes in nailfold capillaroscopy (score = 3)  com-
pared to subgroups with normal capillaroscopic pat-
tern or with mild abnormalities (p < 0.001). Kataka-
mi et al. observed increased levels and positive cor-
relations between IL-18, sE-selectin and sICAM
serum levels in 77 patients with type 1 diabetes. In
the same study, a correlation between IL-18 con-
centration and metabolic control of the disease was
found [23]. Moreover, elevated IL-18 serum levels
were reported in patients with type 1 diabetes com-
plicated by nephropathy [26]. Other authors have
also demonstrated increased IL-18 serum levels in
relation to the presence of persistent complications
in the course of type 2 diabetes [12].
In the present study, we demonstrated significantly
higher serum levels of sE-selectin and IL-18 in type 1
diabetic patients compared to healthy controls. More-
over, we found a relationship between elevated se-
rum sE-selectin and IL-18 concentrations and the
severity of microvascular capillaroscopy changes in
patients with type 1 diabetes.
In conclusion, our findings suggest that abnorma-
lities in nailfold capillaroscopy may reflect the sever-
ity of microvascular changes in the course of type 1
diabetes. Therefore,  nailfold capillaroscopy may be
a useful diagnostic and prognostic tool for the better
evaluation and monitoring of microvascular compli-
cations in type 1 diabetic patients. Further investiga-
tions of the role of microvascular changes in the de-
velopment of diabetic complications may be crucial
for better diagnosis, monitoring  and more effective
strategies for the treatment of organ dysfunction in
diabetic patients.
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